Mitotane will reduce the level or result of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of abemaciclib with strong CYP3A4 inducers decreases plasma concentration of abemaciclib and its metabolites. Employing this medication with any of the subsequent medicines may perhaps cause an increased risk https://deferoxamine-mesylate46891.wizzardsblog.com/34851248/pt2399-an-overview